MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KALV made $40,863K in revenue. -$23,474K in net income. Net profit margin of -57.45%.

Income Overview

Revenue
$40,863K
Net Income
-$23,474K
Net Profit Margin
-57.45%
EPS
-$0.43
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Partnership And Other Revenue

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-07-31
Total revenues
40,863 26,402* 13,692 1,426
Cost of revenue
3,090 348* 1,232 590
Research and development
12,420 -7,361* 11,993 15,162
Selling, general and administrative
48,795 -12,136* 46,517 44,683
Total operating expenses
64,305 -19,150* 59,742 60,435
Operating gain
-23,442 45,552* -46,050 -59,009
Interest income
2,548 203* 1,875 1,849
Interest expense
5,586 477* 4,757 3,522
Foreign currency exchange (gain) loss
-52 -1,531* -884 1,925
Other income, net
3,045 3,593* 2,491 818
Total other (expense) income
-45 1,788* -1,275 1,070
Gain before income tax expense
-23,487 47,339* -47,325 -57,939
Income tax (benefit) expense
--7,504* 2,157 2,157
Net gain
-23,487 54,843* -49,482 -60,096
Foreign currency translation gain (loss)
280 -1,464* 911 -604
Unrealized holding loss (gain) on marketable securities
-278 9* 187 18
Reclassification adjustment for realized holding (income) gain on marketable securities included in net gain
-11 -810* 771 587
Total other comprehensive income (loss)
13 -646* 327 -1,173
Comprehensive gain
-23,474 54,197 -49,155 -61,269
Basic EPS
-0.43 0.999 -0.92 -1.12
Diluted EPS
-0.43 0.999 -0.92 -1.12
Basic Average Shares
54,583,424 54,229,212 53,883,681 53,497,128
Diluted Average Shares
54,583,424 54,229,212 53,883,681 53,497,128
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Foreign currencytranslation gain (loss)$280K Reclassification adjustment forrealized holding...-$11K Comprehensive gain-$23,474K Total othercomprehensive income (loss)$13K Unrealized holding loss(gain) on marketable...-$278K Net gain-$23,487K Gain before incometax expense-$23,487K Product$39,165K Partnership And OtherRevenue$1,698K Operating gain-$23,442K Total other (expense)income-$45K Total revenues$40,863K Other income, net$3,045K Interest income$2,548K Total operatingexpenses$64,305K Interest expense$5,586K Foreign currencyexchange (gain) loss-$52K Selling, general andadministrative$48,795K Research and development$12,420K Cost of revenue$3,090K

KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals, Inc. (KALV)